IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells - PubMed (original) (raw)

. 1995 Feb 1;154(3):1280-6.

Affiliations

PMID: 7822797

IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells

S Beissert et al. J Immunol. 1995.

Abstract

IL-10 inhibits Langerhans cell (LC) Ag presentation to Th1 clones. As LC are capable of presenting tumor-associated Ags (TAA) for primary and secondary tumor immune responses, we examined the effect of IL-10 on LC Ag presentation in a model of immunity to the S1509a spindle cell tumor (H-2a). Because induction of immunity to S1509a requires exposure of LC to granulocyte-macrophage (GM)-CSF, this system also allowed us to study the regulatory interactions of GM-CSF and IL-10 on LC. Naive CAF1 (H-2a/d) mice could be immunized against S1509a by injection with GM-CSF-exposed and TAA-pulsed epidermal cells (EC) as assessed by inhibition of the growth of inoculated tumor cells. Incubation of EC in IL-10 before GM-CSF exposure completely inhibited Ag presentation in this system. Significantly, neither co-incubation of EC in IL-10 and GM-CSF (without preincubation in IL-10) nor IL-10 treatment after GM-CSF incubation was able to exert a down-regulatory effect. The ability of IL-10 to modulate EC presentation of TAA for a secondary immune response was also examined. EC were pulsed with TAA in vitro and then injected into a hind footpad of tumor-immune mice with 24 h swelling assessed as a measure of delayed-type hypersensitivity. Preincubation in IL-10 before TAA exposure significantly inhibited elicitation of delayed-type hypersensitivity with or without subsequent exposure to GM-CSF. Co-incubation of EC in IL-10 and GM-CSF or exposure to IL-10 after GM-CSF led to a normal response. These data indicate that IL-10 may serve as an important regulator of LC Ag-presenting function for tumor immune responses. IL-10 appears to specifically prevent the GM-CSF-induced maturation of LC Ag-presenting function when treatment with IL-10 occurs before exposure to GM-CSF but does not reverse the established mature state.

PubMed Disclaimer

Cited by

Heterogeneity and Functions of Tumor-Infiltrating Antibody Secreting Cells: Lessons from Breast, Ovarian, and Other Solid Cancers.
Lounici Y, Le Saux O, Chemin G, Wajda P, Barrin S, Berthet J, Caux C, Dubois B. Lounici Y, et al. Cancers (Basel). 2022 Sep 30;14(19):4800. doi: 10.3390/cancers14194800. Cancers (Basel). 2022. PMID: 36230721 Free PMC article. Review.
Effect and Molecular Mechanisms of Traditional Chinese Medicine on Tumor Targeting Tumor-Associated Macrophages.
He J, Yin P, Xu K. He J, et al. Drug Des Devel Ther. 2020 Feb 28;14:907-919. doi: 10.2147/DDDT.S223646. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32184560 Free PMC article. Review.
A Common SNP of IL-10 (-1082A/G) is Associated With Increased Risk of Premenopausal Breast Cancer in South Indian Women.
Vinod C, Jyothy A, Vijay Kumar M, Raman RR, Nallari P, Venkateshwari A. Vinod C, et al. Iran J Cancer Prev. 2015 Aug;8(4):e3434. doi: 10.17795/ijcp-3434. Epub 2015 Aug 24. Iran J Cancer Prev. 2015. PMID: 26478792 Free PMC article.
IL-10 enhances CTL-mediated tumor rejection by inhibiting highly suppressive CD4+ T cells and promoting CTL persistence in a murine model of plasmacytoma.
Wang L, Liu JQ, Talebian F, Liu Z, Yu L, Bai XF. Wang L, et al. Oncoimmunology. 2015 May 13;4(7):e1014232. doi: 10.1080/2162402X.2015.1014232. eCollection 2015 Jul. Oncoimmunology. 2015. PMID: 26140236 Free PMC article.
Immune Dysregulation in Patients Persistently Infected with Human Papillomaviruses 6 and 11.
Lucs AV, DeVoti JA, Hatam L, Afzal A, Abramson AL, Steinberg BM, Bonagura VR. Lucs AV, et al. J Clin Med. 2015 Mar;4(3):375-88. doi: 10.3390/jcm4030375. J Clin Med. 2015. PMID: 26023354 Free PMC article.

IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells - PubMed (original) (raw)